Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Cash & Current Investments (2018 - 2025)

Dna X's Cash & Current Investments history spans 8 years, with the latest figure at $1.3 million for Q4 2025.

  • Quarterly results put Cash & Current Investments at $1.3 million for Q4 2025, down 83.79% from a year ago — trailing twelve months through Dec 2025 was $1.3 million (down 83.79% YoY), and the annual figure for FY2025 was $1.3 million, down 83.79%.
  • Cash & Current Investments for Q4 2025 was $1.3 million at Dna X, down from $4.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $13.9 million in Q1 2021 to a low of $102000.0 in Q2 2024.
  • The 5-year median for Cash & Current Investments is $5.2 million (2025), against an average of $5.7 million.
  • The sharpest move saw Cash & Current Investments plummeted 98.95% in 2024, then soared 5235.29% in 2025.
  • Year by year, Cash & Current Investments stood at $12.3 million in 2021, then tumbled by 87.77% to $1.5 million in 2022, then skyrocketed by 539.17% to $9.6 million in 2023, then fell by 16.2% to $8.0 million in 2024, then crashed by 83.79% to $1.3 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $1.3 million, $4.3 million, and $5.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.